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presence of CAD based on angio or documented MI.. There were
11250 patients, we divided the cohort in to 2 Groups, namely, CAD
+ (Group 1) and CAD e (Group 2).
Results: Group-wise comparison showed the following Results:
Mean age in Group I significantly higher. (56.36 Vs 52.95) p z
0.0000. There were significantly higher number of males in Group
1. (6125 Vs 2682) p z 0.0000. DM (41.5%Vs 21.8%) p z 0.0000.
Smoking (13.1%Vs 5.7%) p z0.0000 were significantly higher in
Group 1. Mean HDL was significantly lower in Group 1. (39.42 Vs
41.75), p z 0.0000.
Stepwise logistic regression was done on 10,615 patients which
showed the following.
From the logistic regression analysis, adjusted for TC, TC/HDL,
HDL/LDL, HDL and HTN it is observed that:
CAD risk 3.037 times higher in males and 2.535 times higher in
DM, 2.107 times higher in smokers, 1.029 times higher with each
unit increase in Age. Not adjusting for Gender, analysis showed
CAD risk is 2.458 times higher in DM and 2.751 times higher in
smokers. Using Logistic regression model we found that in a 55
year old male, presence of diabetes increases the risk further by
18.82% and presence of smoking further increases by 9.15%.
Conclusion: 1) Traditional risk factors as age, DM, smoking have
significant association with CAD. 02) Average lipoprotein levels
were lower in our population.
High dose statin study
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Background: There has been no Indian data on high dose statin in
our country.
Aims: To assess the tolerability and safety (A 80) in high risk
patients.
Methods: This is a retrospective observational study. 272
consecutive patients who were prescribed A80 and could be fol-
lowed for 2 years formed the cohort. Data were retrieved from
inpatient and outpatient records. Baseline demographics, initial
diagnosis, interventional procedure done, list of concomitant
medications, side effect profile, reason for dose reduction were all
obtained and analysed.
Results: There were 238 males (87.5%) & 34 females (12.5%) Mean
age was 56.4 year. HT was seen in 119 (43.75 %). DM in 109 (40.07%)
Dyslipidemia in 114 (41.9 %) Tobacco use in 75 (27.57%) 236 (86.7%)
patients presented with acute coronary syndrome. 204 (75 %)
STEMI; 17 (6.25%) NSTEMI and 14with unstable angina: (5.14%) 116
patients had 2VD on CAG. Mean TC 186, HDL 36.01, LDL 119, TG
143; Mean reduction in LDL was 49.3% in six months. 83 (30.51%)
patients had their dose reduction for various reasons. Maximal
reduction was seen in first six months, [(49/83). 62%]. 35 patients
had dose reduction due to financial reasons (43%). 29 patients had
dose reduction without any reason in the case file (34%). 15 pa-
tients had dose reduction due to side effects (18.07%). Cough was
seen in 4 (1.47%), Abdominal pain 2 (0.735%), Constipation in 3
(1.10%), Headache in 3 (1.10%) and Tiredness in 1, necessitating
dose reduction. One each had SGPT and CK elevation requiring
dose reduction. CK elevation more than 10 times was seen in one
patient requiring stopping the statin.
Conclusion: High dose statin therapy (A80) is safe, tolerable with
minimal side effects and should be prescribed to all deserving
patients similar to our study group.
Our experience of CTO angioplasties
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Background: Chronic total occlusion is defined as complete oc-
clusion of the coronary vessel with TIMI O flow, present for an
estimated duration of >3 months. Studies have found a frequency
of 15-20% of CTO in angiographies. Chronic total occlusion PCI has
experienced significant growth in the last few years with the
adaptation and refinement of advanced techniques.
Methods: Over the past 3 years, more than 250 CTO PTCA were
performed at ourcentre. We present an analysis of these CTO
PTCA done at our centre. Subjects were analysed with respect to
demographics, presentation, outcome and material used.
Results: Of the patients, males composed 72 % and females 28 % of
patients. The predominant presentation was chronic stable
angina (42%) followed by unstable angina (24%) and NSTEMI. The
average LV function was 45%, while viability of myocardium was
confirmed with stress thallium scans. The vessels involved were
LAD: 38%, RCA: 42%, and LCX: 20%. In 82% procedures, TIMI III flow
could be established without any complications. 12% procedures
were unsuccessful, primarily due to inability to cross the lesion.
Complications occured in 15 % of CTO PTCA. Of these, the com-
monest was: flap formation (7%). Perforation occured in 6% of
patients, of which 2 required placement of a covered stent, while
the others were managed by balloon occlusion. 2% patients
required pericardial tapping. Contrast induced nephropathy
occured in 1 patient, while 4 patients succumbed in the peri-
procedural period. 64% of the lesions were negotiated using reg-
ular angioplasty wires (our workhorse FIELDER FC PTCA wires),
while 36% required use of CTO wires.
Conclusion: CTO PTCA is one of the final frontiers of coronary
interventions, our experience shows that CTO PTCA shows
promising results, with complications rates that are progressively
diminishing. We would like to highlight that a majority CTO PTCA
were carried out using regular angioplasty wires with balloon
support as opposed to CTO wires.
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Background: Association of Red blood cell distribution width
(RDW) and coronary artery disease (CAD) is well established. But
other erythrocyte parameters Mean corpuscular volume (MCV),
Mean corpuscular Haemoglobin (MCH), Mean corpuscular hae-
moglobin concentration (MCHC) importance in pathogenesis of
CAD is not studied.
Methods: Retrospective analysis of 765 patients’ records (with
complete Haemogram), who underwent coronary angiogram for
suspected CAD in yearr 2013 at a tertiary care hospital were
included in this study. Patients were grouped into angiography
positive (AGP) (N¼438), angiography negative (AGN) (N¼327) based
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on coronary angiogram. Patients with normal coronary angiogram
and those with mild disease were grouped under AGN, and those
requiring revascularization either by PCI or Coronary artery
bypass grafting were grouped under AGP. Complete blood cell
counts were analyzed with auto analyzers. Red cell parameters
were compared between the two groups. Statistical analysis was
performed with student T test.
Results: Of 765 patients, 238 were females 527 were males with
mean age of 55.4 ± 11 years. Out of 765 coronary angiograms
performed 438 patients were grouped under AGP and 327 pa-
tients were grouped under AGN. There was no significant dif-
ference between the AGP and AGN groups in mean Hemoglobin
concentration (p¼0.09), Red cell count (p¼0.06), MCH (p¼0.8),
MCHC (p¼0.6) but there was a statistically significant difference
in MCV (p¼0.004), total leukocyte count (p¼0.007) and platelet
count (p¼0.018). A positive correlation was observed with MCV,
TLC, Platelet count with coronary artery disease which were
significantly higher in patients with proven coronary artery
disease.
Conclusions: These findings suggest that altered Red blood cells
may play a role in pathogenesis of coronary artery disease. This
change in MCV is cause or effect is to studied.
Outcome of primary angioplasty in high volume
tertiary care centre
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Aims: To determine the outcome of primary PCI in high volume
tertiary care centre.
Methods: We evaluated 137 patients who underwent primary PCI
for acute STEMI at our institute from JAN 2013 to DEC 2103(1 year)
retrospectively.
Results: A total of 137 patients were included in the study. The
mean age of patients was 54.0±11.5 years. On admission, 49
patients (35.8%) had diabetes, 52 patents (38%) had hyperten-
sion, 79 patients (58%) had acute AWMI, and 66 patients (48.7%)
were smokers. Cardiogenic shock, complete heart block, ven-
tricular fibrillation were encountered in 8 patients (5.7%), 10
patients (7.2%) and 12 patients (8.9%) respectively at hospital
admission.
The mean door-to balloon time was 62.5±15 minutes. Infarct
related artery was eLAD (58%), LCX (12%), and RCA (30%) of pa-
tients. Multivessel disease was seen in 12 patients (6.4%). POBA
was done in 5 patients (3.9%) and rest of the patients had stent
implantation. The incidence of angiographic no reflow was seen
in 5 patients (3.9%). The mean hospital stay was 5.2±3.3 days.
During hospital stay, the in hospital mortality was 5 patients
(3.6%) out of which 4 patients (2.8%) died of a cardiac cause. Target
vessel revascularization, major bleeding and minor bleeding were
observed in 1(1.1%), 1(1.1%) and 3(2.2%) respectively. Acute stent
thrombosis occurred in 1 patient (1.2%).
Conclusion: Primary PCI is an effective method in achieving
complete revascularization of infarct related artery. Successful in
hospital results depend not only on the experience of the oper-
ator, but also on the rapidity of reperfusion.
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Background: Cardiac Syndrome X describes patients with angina,
compatible findings with myocardial ischemia and normal coro-
nary angiograms. It is an important clinical entity that should be
distinguished from ischemic heart disease caused by obstructive
coronary artery disease.
Aims: Several studies have already established the predominance
of Syndrome X in female population. In our study, we analyse the
prevalence of Syndrome X in female population and the signifi-
cance of age, menopausal status, diabetes and hypertension with
syndrome X.
Methods: This is a observational study conducted in the Depart-
ment of Cardiology in a tertiary care centre in Chennai during the
period of May to July 2014. A total of 50 female patients with
anginal symptoms and evidence of myocardial ischemia in the
form of positive treadmill test by Bruce protocol were included.
They underwent diagnostic coronary angiogram. The pattern of
coronary artery involvement was analysed.
Results: Out of the 50 female patients who underwent coronary
angiograms, 20 (40%) patients had normal coronary arteries. Of
these 20 patients, 16 (80%) were post-menopausal and 4 (20%)
were pre-menopausal. Diabetic population among the patients
with normal coronaries were 12 (60%), hypertensive non-diabetic
population were 5 (25%) patients, non-diabetic non-hypertensive
population were 3 (15%) patients. Average age among patients
with normal coronary angiogram was 54 years, with average age
being lower in diabetics (52 years) compared to non diabetics (58
years).
Conclusion: Cardiac syndrome X has a higher prevalence in fe-
male population in the post menopausal age group. Diabetic
population was associated with greater incidence of syndrome X
with a lower average age compared to non diabetic women. The
analysis of diabetic and non-diabetic patients with cardiac syn-
drome X in this study has shown that diabetic population has a
greater involvement of coronary microcirculation at an earlier
age.
Does the antiplatelet regimen needs a change in
CKD patients: a platelet inhibition study
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Background: Higher coronary in-stent thrombosis and bleeding
complications on anti-platelet agents are more common in
Chronic Kidney Disease vs. non-Chronic Kidney Disease patients.
Poor inhibition of platelet aggregation by anti-platelet agents
predicts future cardiovascular events. Clinical practice guidelines
are ambiguous about the use of these agents in Chronic Kidney
Disease due to lack of controlled studies. The investigators
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